25 May 2013
Keywords: cortecs, banks, oral, insulin, product, wake, macritonin
Article | 01 July 1999
Beleaguered UK biotechnology company Cortecs, which following anexternal review is positioning itself as an early-stage R&D company, last week ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.